Oxcarbazepine in painful diabetic neuropathy: A randomized, placebo-controlled study

European Journal of Pain

Volumn 9, Issue 5, 2005, Pages 543-

  Dogra, Sunil ^a   Beydoun, Said ^b   Mazzola, Jennifer ^c   Hopwood, Margaret ^c   Wan, Ying ^c  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Anti epileptic drug; Diabetic neuropathy; Neuropathic pain; Oxcarbazepine; Randomized study

Indexed keywords

OXCARBAZEPINE;

ADULT; AGED; ANALGESIA; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEUROPATHY; DIARRHEA; DISEASE SEVERITY; DIZZINESS; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FATIGUE; FEMALE; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; NEUROPATHIC PAIN; PAIN ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SOMNOLENCE; STATISTICAL SIGNIFICANCE; TITRIMETRY; TREMOR; VISUAL ANALOG SCALE; VISUAL IMPAIRMENT; VOMITING;

EID: 24044458603     PISSN: 10903801     EISSN: 15322149     Source Type: Journal    
DOI: 10.1016/j.ejpain.2004.11.006     Document Type: Article

References (45)

1. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2003;26(Suppl 1):S33-50.
2. M. Backonja, A. Beydoun, K.R. Edwards, S.L. Schwartz, V. Fonseca, M. Hes, L. LaMoreaux, and E. Garofalo Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial JAMA 280 1998 1831 1836
3. J. Berg, J. Dunbar-Jacob, and J.M. Rohay Compliance with inhaled medications: the relationship between diary and electronic monitor Ann Behav Med 20 1998 36 38
4. A. Beydoun, S. Kobetz, and E. Carrazana Efficacy of oxcarbazepine in the treatment of painful diabetic neuropathy Clin J Pain 20 2004 174 178
5. Beydoun A, Schmidt D, D'Souza J, on behalf of the Oxcarbazepine Study Group. Meta-analysis of comparative trials of oxcarbazepine versus carbamazepine in trigeminal neuralgia. J Pain 2002;3:749 [Abstract].
6. P.A. Bill, U. Vigonius, H. Pohlmann, C.A. Guerreiro, S. Kochen, D. Saffer, and A. Moore A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy Epilepsy Res 27 1997 195 204
7. F.G. Campbell, J.G. Graham, and K.J. Zilkha Clinical trial of carbamazepine (tegretol) in trigeminal neuralgia J Neurol Neurosurg Psychiatry 29 1966 265 267
8. E. Carrazana, and I. Mikoshiba Rationale and evidence for the use of oxcarbazepine in neuropathic pain J Pain Symptom Manage 25 2003 S31 S35
9. M.S. Chong, and Z.H. Bajwa Diagnosis and treatment of neuropathic pain J Pain Symptom Manage 25 2003 S4 S11
10. W. Christe, G. Kramer, U. Vigonius, H. Pohlmann, B.J. Steinhoff, M.J. Brodie, and A. Moore A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy Epilepsy Res 26 1997 451 460
11. Dam M, Ekberg R, Løyning Y, Waltimo O, Jakobsen K, The Scandinavian Oxcarbazepine Study Group. A double-blind study comparing oxcarbazepine and carbamazepine in patients with newly diagnosed, previously untreated epilepsy. Epilepsy Res 1989;3:70-6.
12. R.H. Dworkin, M. Backonja, M.C. Rowbotham, R.R. Allen, C.R. Argoff, and G.J. Bennett Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations Arch Neurol 60 2003 1524 1534
13. E. Eisenberg, Y. Lurie, C. Braker, D. Daoud, and A. Ishay Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study Neurology 57 2001 505 509
14. Elashoff JD. Query Advisor Version 4.0 User's Guide. Statistical solutions. Los Angeles, California; 2000.
15. J.T. Farrar, J.A. Berlin, and B.L. Strom Clinically important changes in acute pain outcome measures: a validation study J Pain Symptom Manage 25 2003 406 411
16. J.T. Farrar, J.P. Young Jr., L. LaMoreaux, J.L. Werth, and R.M. Poole Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale Pain 94 2001 149 158
17. A. Fox, C. Gentry, S. Patel, A. Kesingland, and S. Bevan Comparative activity of the anti-convulsants oxcarbazepine, carbamazepine, lamotrigine and gabapentin in a model of neuropathic pain in the rat and guinea-pig Pain 105 2003 355 362
18. M.M. Guerreiro, U. Vigonius, H. Pohlmann, M.L. de Manreza, N. Fejerman, and S.A. Antoniuk A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in children and adolescents with epilepsy Epilepsy Res 27 1997 205 213
19. R.N. Jamison, R.H. Gracely, S.A. Raymond, J.G. Levine, B. Marino, and T.J. Herrmann Comparative study of electronic vs. paper VAS ratings: a randomized, crossover trial using healthy volunteers Pain 99 2002 341 347
20. J.M. Killian, and G.H. Fromm Carbamazepine in the treatment of neuralgia. Use of side effects Arch Neurol 19 1968 129 136
21. M.J. McLean, M. Schmutz, A.W. Wamil, H.R. Olpe, C. Portet, and K.F. Feldmann Oxcarbazepine: mechanisms of action Epilepsia 35 Suppl 3 1994 S5 S9
22. D.M. McNair, M. Lorr, and L.F. Droppleman Profile of mood states: manual 1981 Educational and Industrial Testing Service San Diego, Calafornia
23. H. McQuay, D. Carroll, A.R. Jadad, P. Wiffen, and A. Moore Anticonvulsant drugs for management of pain: a systematic review Brit Med J 311 1995 1047 1052
24. National Institute of Diabetes and Digestive and Kidney Diseases. Diabetic neuropathies: the nerve damage of diabetes. Available at http://www.niddk.nih.gov/health/diabetes/pubs/neuro/neuro.htm; 2003. Accessed June 24, 2004.
25. C.F. Nicol A four year double-blind study of tegretol in facial pain Headache 9 1969 54 57
26. J. Rosenstock, M. Tuchman, L. LaMoreaux, and U. Sharma Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial Pain 110 2004 628 638
27. M.A. Royal, M. Jenson, B. Bhakta, I. Gunyea, V. Movva, and S. Ward An open-label trial of oxcarbazepine in patients with complex regional pain syndrome refractory to gabapentin J Pain 3 2002 763 [Abstract]
28. J.A. Rull, R. Quibrera, H. Gonzalez-Millan, and C.O. Lozano Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol): double blind crossover trial Diabetologia 5 1969 215 218
29. K.E. Schmader Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy Clin J Pain 18 2002 350 354
30. D. Schmidt, S. Arroyo, M. Baulac, M. Dam, O. Dulac, and M.L. Friis Recommendations on the clinical use of oxcarbazepine in the treatment of epilepsy: a consensus view Acta Neurol Scand 104 2001 167 170
31. D. Schmidt, and R. Sachdeo Oxcarbazepine for treatment of partial epilepsy: a review and recommendations for clinical use Epilepsy Behav 1 2000 396 405
32. A. Stefani, A. Pisani, M. De Murtas, N.B. Mercuri, M.G. Marciani, and P. Calabresi Action of GP 47779, the active metabolite of oxcarbazepine, on the corticostriatal system. II. Modulation of high-voltage-activated calcium currents Epilepsia 36 1995 997 1002
33. A.A. Stone, S. Shiffman, J.E. Schwartz, J.E. Broderick, and M.R. Hufford Patient non-compliance with paper diaries BMJ 324 2002 1193 1194
34. K.H. Todd, and J.P. Funk The minimum clinically important difference in physician-assigned visual analog pain scores Acad Emerg Med 3 1996 142 146
35. K.H. Todd, K.G. Funk, J.P. Funk, and R. Bonacci Clinical significance of reported changes in pain severity Ann Emerg Med 27 1996 485 489
36. M.W. Tsang, M. Mok, G. Kam, M. Jung, A. Tang, and U. Chan Improvement in diabetes control with a monitoring system based on a hand-held, touch-screen electronic diary J Telemed Telecare 7 2001 47 50
37. J.M. van Gerven, R.C. Schoemaker, L.D. Jacobs, A. Reints, M.J. Ouwersloot-van der Meij, and H.G. Hoedemaker Self-medication of a single headache episode with ketoprofen, ibuprofen or placebo, home-monitored with an electronic patient diary Brit J Clin Pharmacol 42 1996 475 481
38. J.A. Van Parys, and H. Meinardi Survey of 260 epileptic patients treated with oxcarbazepine (Trileptal) on a named-patient basis Epilepsy Res 19 1994 79 85
39. G. Velikova, E.P. Wright, A.B. Smith, A. Cull, A. Gould, and D. Forman Automated collection of quality-of-life data: a comparison of paper and computer touch-screen questionnaires J Clin Oncol 17 1999 998 1007
40. A. Wamil, C. Portet, P.K. Jensen, M. Schmutz, and M.J. McLean Oxcarbazepine and its monohydroxy metabolite limit action potential firing by mouse central neurons in cell culture Epilepsia 32 1991 65 66
41. S. Ward, M. Royal, M. Jenson, B. Bhakta, I. Gunyea, and V. Movva An open-label trial of oxcarbazepine in patients with radiculopathy refractory to gabapentin J Pain 3 2002 765 [Abstract]
42. J.E. Ware Jr., K.K. Snow, M. Konsinski, and B. Gandek SF-36 Health survey; manual and interpretation guide 1993 The Health Institute, New England Medical Center Boston, Mass
43. K. Wellington, and K.L. Goa Oxcarbazepine: an update of its efficacy in the management of epilepsy CNS Drugs 15 2001 137 163
44. H.S. White Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs Epilepsia 40 1999 S2 S10
45. C.J. Woolf, and R.J. Mannion Neuropathic pain: aetiology, symptoms, mechanisms, and management Lancet 353 1999 1959 1964